Minimising harm: Human variation and adverse drug reactions (ADRs)

British Journal of Clinical Pharmacology

Volumn 65, Issue 4, 2008, Pages 451-452

  Ritter, J M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIFUNGAL AGENT; CLOPIDOGREL; CYTOCHROME P450; CYTOCHROME P450 2C19; EFAVIRENZ; NELFINAVIR; NONSTEROID ANTIINFLAMMATORY AGENT; TRAMADOL; VORICONAZOLE;

CURRICULUM; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GASTROINTESTINAL TOXICITY; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIVIDUALIZATION; LOW DRUG DOSE; OPPORTUNISTIC INFECTION; PEPTIC ULCER; POSTGRADUATE EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; PROBLEM SOLVING; RISK BENEFIT ANALYSIS; RISK REDUCTION; THROMBOSIS; THROMBOSIS PREVENTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CLINICAL TRIALS AS TOPIC; FEMALE; HEALTH CARE COSTS; HUMANS; LEGISLATION, DRUG; MALE; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; SAFETY MANAGEMENT;

EID: 40549109312     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03170.x     Document Type: Editorial

References (12)

1. Prugnaud J-L. Similarity of biotechnology-derived medicinal products: specific problems and new regulatory framework. Br J Clin Pharmacol 2008 65 : 619 20.
2. Bakker MK, Kölling P, van den Berg PB, De Walle HEK, De Jong van den Berg LTW. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 2008 65 : 600 6.
3. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients Br Med J 2004 329 : 15 19.
4. Wester K, Jönsson AK, Spigset O, Druid H, Hägg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 2008 65 : 573 9.
5. Tobaiqy M, Mclay J, Ross S. Foundation year 1 doctors and clinical pharmacology and therapeutics teaching. A retrospective view in light of experience. Br J Clin Pharmacol 2007 64 : 363 372.
6. Balakrishnan S, Jhah R. Letter to the Editor: Prophylactic use of gastro-protective agents in patients on low-dose aspirin. Br J Clin Pharmacol 2008 65 : 621 2.
7. Back DJ, Gibbons SE. Letter to the Editor: Response to 'Communicating Information about Drug Interactions Br J Clin Pharmacol 2008 65 : 617 18.
8. Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol 2008 65 : 396 406.
9. Damle B, LaBadie R, Crownover P, Glue P. Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers. Br J Clin Pharmacol 2008 65 : 523 30.
10. Tørring ML, Riis A, Christensen S, Thomsen RW, Jepsen P, Søndergaard J, Sørensen HT. Perforated peptic ulcer and short-term mortality among tramadol users. Br J Clin Pharmacol 2008 65 : 565 72.
11. Hirt D, Mentré F, Tran A, Rey E, Auleley S, Salmon D, Duval X, Tréluyer J-M, COPHAR2-ANRS Study Group. Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients. Br J Clin Pharmacol 2008 65 : 548 57.
12. 12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease. Br J Clin Pharmacol 2008 65 : 540 7.